Document is current
Any future updates will be listed below
-
Authors
Setton, Jeremy
Selenica, Pier
Mukherjee, Semanti
Shah, Rachna
Pecorari, Isabella https://orcid.org/0000-0002-1474-2553
McMillan, Biko
Pei, Isaac X. https://orcid.org/0000-0001-9961-6152
Kemel, Yelena https://orcid.org/0000-0002-5042-5651
Ceyhan-Birsoy, Ozge
Sheehan, Margaret
Tkachuk, Kaitlyn
Brown, David N.
Zhang, Liying
Cadoo, Karen
Powell, Simon https://orcid.org/0000-0002-8183-4765
Weigelt, Britta https://orcid.org/0000-0001-9927-1270
Robson, Mark https://orcid.org/0000-0002-3109-1692
Riaz, Nadeem https://orcid.org/0000-0001-9873-5862
Offit, Kenneth
Reis-Filho, Jorge S. https://orcid.org/0000-0003-2969-3173
Mandelker, Diana https://orcid.org/0000-0003-4154-0567
-
Funding
Funding for this research was provided by:
National Cancer Institute at the National Institutes of Health Paul Calabresi Career Development Award for Clinical Oncology
Breast Cancer Research Foundation; the Sarah Jenkins Fund
- License Information
-
More Information
Article History
Received: 17 July 2020
Accepted: 24 August 2021
First Online: 11 October 2021
Competing interests
: J.S.R.-F. is a consultant with paid honoraria of Goldman Sachs and REPARE Therapeutics, a member of the scientific advisory boards of Volition RX and Paige.AI, and an ad hoc member of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Roche, Genentech and InVicro. He is also a deputy editor for NPJ Breast Cancer. The remaining authors declare no competing interests.
